.png?trim=0,0,0,0&width=1200&height=800&crop=1200:800 "John Rentoul answers your questions on Starmer’s trade deals – and their impact on the UK’s EU bargaining power – UK Times")
Dr Manuela Gazzard has been reappointed as Non-Executive Director of the Crown Commercial Service following the end of her term on 31st January 2025.
She has been reappointed for another term of 3 years, starting on 1st February 2025. She will serve as Non-Executive Director until 31st August 2027.
The Crown Commercial Service is an Executive Agency and Trading Fund of the Cabinet Office.
It is responsible for managing the procurement of common goods and services, increasing savings for the taxpayer by centralising buying requirements, and leading on procurement policy on behalf of the government.
You can read more about the Crown Commercial Service here.
Dr Manuela Gazzard is currently Group Director of Regulatory Services at BSI. She has over 20 years of leadership experience in the global life sciences sector including pharmaceuticals, medical devices, biotech, and other related fields.
She has held positions as Managing Director, NovaPrep and Lab Services at Novacyt; Group Commercial Director, Johnson Matthey/Macfarlan Smith; and Director positions at Johnson & Johnson/Janssen and Boehringer Ingelheim.
